Aazam Gholami Shahrebabak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aazam Gholami Shahrebabak has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Amirhossein Shahpar
Gastrointestinal Research Center Kerman University of Medical Sciences Kerman Iran
2 shared publications- Nazanin Zeinali Nezhad
Physiology Research Center Institute of Neuropharmacology, Kerman University of Medical Sciences Kerman Iran
2 shared publications Azam Gholami Shahrbabak
Department of Pediatrics, Afzalipour Hospital, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication- Mehdi Azizmohammad Looha
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication - Sahar Beyranvand
Department of Medicine, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication - Shokoufeh Ahmadipour
Department of Medicine, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in BMC Pediatrics
Hearing impairment and ototoxic medication exposure in children with cystic fibrosis: a multicenter cross-sectional study
Purpose: To estimate the prevalence of hearing impairment and explore its associations with demographic, clinical, and medication-use characteristics in Iranian children and adolescents with cystic fibrosis (CF). Methods: This multicenter cross-sectional study included 193 participants younger than 18 years before age rounding with a documented clinical diagnosis of CF in Lorestan, Kerman, and Khuzestan during 2023–2024. Hearing status was obtained from audiological reports under an operational ≥30 dB definition. Medication use was recorded as binary indicators without route-specific or cumulative exposure information. Group comparisons used exact conditional Wilcoxon rank-sum and Fisher exact tests. Exploratory associations were estimated using univariable Firth penalized logistic regression. Results: Median age was 12.00 years (IQR, 11.00–14.00), and 107 participants (55.4%) were female. Six participants had hearing impairment, giving a prevalence of 3.1% (exact 95% CI, 1.1%–6.6%); all six were classified as having mild sensorineural loss. Impairment occurred in 6 of 64 participants with tobramycin use and none of 129 without use. The Firth estimate suggested an association (OR, 28.78; profile penalized-likelihood 95% CI, 3.31–3776.23; P < 0.001), with substantial imprecision. The azithromycin comparison was inconclusive. Conclusion: Hearing impairment was uncommon under the study definition. The exploratory, unadjusted tobramycin association does not establish causation or a route-specific effect. Larger prospective multicenter studies with detailed medication exposure histories and baseline and repeated hearing assessments are needed.
- 31 October 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessHearing impairment and ototoxic medication exposure in children with cystic fibrosis: a multicenter cross-sectional study
Purpose: To estimate the prevalence of hearing impairment and explore its associations with demographic, clinical, and medication-use characteristics in Iranian children and adolescents with cystic fibrosis (CF). Methods: This multicenter cross-sectional study included 193 participants younger than 18 years before age rounding with a documented clinical diagnosis of CF in Lorestan, Kerman, and Khuzestan during 2023–2024. Hearing status was obtained from audiological reports under an operational ≥30 dB definition. Medication use was recorded as binary indicators without route-specific or cumulative exposure information. Group comparisons used exact conditional Wilcoxon rank-sum and Fisher exact tests. Exploratory associations were estimated using univariable Firth penalized logistic regression. Results: Median age was 12.00 years (IQR, 11.00–14.00), and 107 participants (55.4%) were female. Six participants had hearing impairment, giving a prevalence of 3.1% (exact 95% CI, 1.1%–6.6%); all six were classified as having mild sensorineural loss. Impairment occurred in 6 of 64 participants with tobramycin use and none of 129 without use. The Firth estimate suggested an association (OR, 28.78; profile penalized-likelihood 95% CI, 3.31–3776.23; P < 0.001), with substantial imprecision. The azithromycin comparison was inconclusive. Conclusion: Hearing impairment was uncommon under the study definition. The exploratory, unadjusted tobramycin association does not establish causation or a route-specific effect. Larger prospective multicenter studies with detailed medication exposure histories and baseline and repeated hearing assessments are needed.
- Open Access
- 1 April 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (4) , e8697
Empyema necessitans as a rare manifestation of Staphylococcus aureus
Key Clinical Message: Empyema necessitans (EN) is a rare complication of empyema, in which pus accumulates within the pleural space and spreads through the chest wall, leading to the formation of a subcutaneous abscess. This condition presents significant diagnostic and therapeutic challenges due to its rarity and potential for serious complications. Here, we present the case of an 8‐year‐old boy with a history of parapneumonic effusion that was incompletely treated due to a lack of fibrinolytic agent injection. He presented with fever, chills, a productive cough, and left‐sided chest pain with yellowish purulent secretions from the left chest wall. The patient was diagnosed with EN caused by Staphylococcus aureus , which has occurred due to inadequate treatment and the lack of administration of a fibrinolytic agent injection for the patient. He was treated with broad‐spectrum antibiotics, video‐assisted thoracic surgery, and a chest tube for complete drainage. The patient showed a smooth and uneventful recovery, highlighting the importance of early diagnosis and prompt treatment of EN to avoid further complications. This case report aims to increase awareness among clinicians about the importance of early recognition and appropriate management of EN to improve patient outcomes.
- 1 April 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (4) , e8697
Open AccessEmpyema necessitans as a rare manifestation of Staphylococcus aureus
Key Clinical Message: Empyema necessitans (EN) is a rare complication of empyema, in which pus accumulates within the pleural space and spreads through the chest wall, leading to the formation of a subcutaneous abscess. This condition presents significant diagnostic and therapeutic challenges due to its rarity and potential for serious complications. Here, we present the case of an 8‐year‐old boy with a history of parapneumonic effusion that was incompletely treated due to a lack of fibrinolytic agent injection. He presented with fever, chills, a productive cough, and left‐sided chest pain with yellowish purulent secretions from the left chest wall. The patient was diagnosed with EN caused by Staphylococcus aureus , which has occurred due to inadequate treatment and the lack of administration of a fibrinolytic agent injection for the patient. He was treated with broad‐spectrum antibiotics, video‐assisted thoracic surgery, and a chest tube for complete drainage. The patient showed a smooth and uneventful recovery, highlighting the importance of early diagnosis and prompt treatment of EN to avoid further complications. This case report aims to increase awareness among clinicians about the importance of early recognition and appropriate management of EN to improve patient outcomes.
- Open Access
- 24 October 2023
- Published by Wiley
Empyema necessitans as a rare manifestation of Staphylococcus aureus
Empyema necessitans as a rare manifestation ofStaphylococcus aureusNazanin Zeinali Nezhad1,Aazam Gholami Shahrebabak2*, Amirhossein Shahpar31 Faculty of Medicine, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, Iran Postal Code: 76169135552 Department of Medical Education, Medical Education Research Center, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, Iran Postal Code: 76169135553 Faculty of Medicine, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, Iran Postal Code: 7616913555*Corresponding author : Aazam Gholami Shahrebabak, Assistant Professor of Pediatrics, Department of Medical Education, Medical Education Research Center, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, IranEmail: a.gholami@kmu.ac.ir
- 24 October 2023
- Published by Wiley
Open AccessEmpyema necessitans as a rare manifestation of Staphylococcus aureus
Empyema necessitans as a rare manifestation ofStaphylococcus aureusNazanin Zeinali Nezhad1,Aazam Gholami Shahrebabak2*, Amirhossein Shahpar31 Faculty of Medicine, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, Iran Postal Code: 76169135552 Department of Medical Education, Medical Education Research Center, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, Iran Postal Code: 76169135553 Faculty of Medicine, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, Iran Postal Code: 7616913555*Corresponding author : Aazam Gholami Shahrebabak, Assistant Professor of Pediatrics, Department of Medical Education, Medical Education Research Center, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Kerman, IranEmail: a.gholami@kmu.ac.ir